IMSC News 1.5000 09/19/2014 05:08:17 Implant Sciences Cp (IM

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Implant Sciences Cp (IMSC) 1.5000 $IMSC

Implant Sciences to Present at NIBA Conference in New York City on September 16, 2014
PR Newswire - Mon Sep 15, 9:35AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced its CEO Glenn D. Bolduc is scheduled to present at the National Investment Banking Association's (NIBA) 132nd Investment Conference on Tuesday, September 16, 2014 at 11:55 am ET. The conference takes place in New York City on September 15th through 17th at the Roosevelt Hotel.

Implant Sciences Sells 12 QS-B220 Explosives Trace Detectors to South Korea's Largest Airport
PR Newswire - Tue Sep 09, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has sold 12 QS-B220 desktop explosives and drugs trace detectors to Incheon International Airport Corporation, operator of Incheon International Airport, the largest airport in South Korea. Implant Sciences' ETDs will be deployed for airport security and will replace existing systems the airport had in place from a competitor.

Implant Sciences to Present at Rodman & Renshaw Conference in New York City on September 10, 2014
PR Newswire - Mon Sep 08, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced its CEO Glenn D. Bolduc is scheduled to present at the Rodman & Renshaw 16th Annual Global Investment Conference on Wednesday, September 10, 2014 at 9:10 am. The conference takes place in New York City on September 8th through 10th at the New York Palace Hotel.

Implant Sciences Sells 43 QS-H150 Explosives Trace Detection Systems in China
PR Newswire - Thu Sep 04, 9:49AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has sold 43 of its QS-H150 Explosives Trace Detection systems to customers in China. Organizations purchasing the systems include a police department and a mass transit authority.

OTC Daily News Report
PR Newswire Europe - Wed Sep 03, 8:05AM CDT
LONDON, September 3, 2014 /PRNewswire/ --

Implant Sciences Wins $1.2 Million Contract for Trace Detectors to EU Country
PR Newswire - Tue Sep 02, 10:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has sold $1.2 million worth of trace detectors to a customer in the European Union. The units will be deployed for critical infrastructure protection and homeland security.

Implant Sciences QS-B220 explosives trace detector approved for passenger and baggage screening at U.S. airports
PR Newswire - Thu Aug 28, 1:32PM CDT
Marking a major milestone for the Company, Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that its QS-B220 desktop explosives trace detector has successfully completed the certification process for the United States Transportation Security Administration's (TSA) Explosive Trace Detection (ETD) qualification requirements for aviation checkpoint and checked baggage screening. The QS-B220 becomes the first ETD with a non-radioactive source to be added to the TSA's Qualified Product List (QPL).

Implant Sciences Responds to Levi & Korsinsky, LLP Press Release /Solicitation
PR Newswire - Mon Aug 11, 6:00AM CDT
In response to a press release/general solicitation by the class action law firm, Levi & Korsinsky, LLP, Glenn D. Bolduc, CEO of Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, said today: "Levi & Korsinsky's press release/solicitation identifies no grounds whatsoever for an investigation of Implant Sciences or its board of directors. The firm has never contacted us directly, and we are not aware of any basis for an investigation. Last week alone, the same firm announced similar 'investigations' and solicitations of plaintiffs with respect to at least two other companies, just as it has done to numerous other public companies, without identifying any reasons. We do not believe this law firm's actions will benefit our shareholders, and we encourage our shareholders and other interested parties to draw their own conclusions about the motivation behind this law firm's actions. I also want to personally thank the many shareholders who have called or emailed me since Levi & Korsinsky's announcement to express their continued support for Implant Sciences."

IMPLANT SCIENCES CORP. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Implant Sciences Corp.
PR Newswire - Fri Aug 08, 11:41AM CDT
Levi & Korsinsky, LLP is investigating Implant Sciences Corp. (OTC: IMSC) in connection with possible claims of breaches of fiduciary duty.

Implant Sciences CEO Invited to Attend Inaugural U.S.-Africa Business Forum by U.S. Department of Commerce
PR Newswire - Tue Aug 05, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced its CEO Glenn D. Bolduc has been invited to attend the U.S.-Africa Business Forum on Tuesday, August 5, 2014 in Washington D.C. Mr. Bolduc is one of a select group of U.S. CEOs invited to the event co-hosted by the U.S. Department of Commerce and Bloomberg Philanthropies. Heads of state will engage with business executives from both sides of the Atlantic in conversations about successes and solutions to build greater access for trade and investment in Africa. President Obama will participate in the conversation with CEOs and government leaders from the U.S. and Africa.

Implant Sciences Ships $550,000 in Explosives Trace Detectors to Domestic and International Customers
PR Newswire - Thu Jul 17, 6:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today stated that it has shipped over $550,000 in previously unannounced orders of QS-H150 and QS-B220s to multiple customers in North America, Europe, Middle East, and Africa. Customers for the handheld and desktop explosives trace detectors include a major international logistics corporation, a construction company, an airport, and the embassy of a foreign nation. The systems will be used for building security and for the screening of air cargo, and airline passengers and baggage.

Implant Sciences Ranked One of the Fastest Growing Public Companies in Massachusetts
PR Newswire - Wed Jul 02, 9:54AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the Boston Business Journal has included Implant Sciences in its annual list of the 50 fastest growing publicly traded companies in Massachusetts. Ranked by two-year revenue growth as of each company's most recent fiscal year, Implant Sciences was 23rd in the state, with an 80.65% increase in revenues for the two-year period from July 1, 2011 to June 30, 2013. For the one-year period between July 1, 2012 and June 30, 2013, Implant Sciences had a revenue increase of 252.82%.

American Association of Airport Executives' CEO Todd Hauptli Visits Implant Sciences
PR Newswire - Tue Jul 01, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that Todd Hauptli, President and Chief Executive Officer of the American Association of Airport Executives (AAAE) visited and toured the Company's headquarters and manufacturing facility.

Implant Sciences Announces Shipment of $400,000 in Explosives Trace Detectors to Customers in Asia, Europe, Africa and Middle East
PR Newswire - Mon Jun 30, 6:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today stated that it has shipped over $400,000 in previously unannounced orders of QS-H150s and QS-B220s to multiple customers in Asia, Europe, Africa and the Middle East. Customers for the handheld and desktop explosives trace detectors include critical infrastructure, air cargo facilities, VIP protection details, and national military organizations.

Implant Sciences to Present at National Investment Banking Association Conference on June 17, 2014 in New York City
PR Newswire - Tue Jun 17, 6:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it will be a part of The National Investment Banking Association's (NIBA) 131st investment conference, taking place June 16th through 18th, 2014 at the Roosevelt Hotel in New York City. Glenn Bolduc, President and CEO of Implant Sciences will present on June 17, 2014.

Implant Sciences Appoints Jonathan Saunders as Manufacturing Manager
PR Newswire - Thu Mar 27, 8:51AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the appointment of Jonathan Saunders into the newly created position of Manufacturing Manager. Mr. Saunders will report to Brenda Baron, Vice President of Manufacturing Operations.

Implant Sciences Receives Product Approval in Germany for its QS-B220 Explosives Trace Detector
PR Newswire - Tue Mar 25, 6:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that its QS-B220 desktop explosives trace detector (ETD) has received regulatory approval from the German Federal Ministry of the Interior for aviation security applications at German airports. The QS-B220 fulfills specifications set by the German Federal Police. With the German Federal Ministry of the Interior approval, the QS-B220 may now be deployed at all non-passenger airport checkpoints for screening of deliveries, food service, and other airport service functions.

Implant Sciences Completes $20,000,000 Refinancing
PR Newswire - Fri Mar 21, 10:08AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the execution of a Note Purchase Agreement with an accredited institutional investor group based in New York City, on March 19, 2014. The Company issued senior secured promissory notes in the principal amount of $20,000,000 to this investor group. Implant Sciences used the proceeds of the loan to pay down its DMRJ Group LLC line of credit as well as some portions of its other indebtedness to DMRJ.

Implant Sciences to Exhibit at Key Conference & Trade Show: Air Cargo 2014
PR Newswire - Tue Mar 18, 8:45AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it will exhibit its QS-B220 explosives trace detector at booth # 802 at Air Cargo 2014. Air Cargo 2014 will take place from March 30 through April 1, 2014 at the Marriott World Center in Orlando, Florida.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading